Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of British Columbia

$841,500.00

Pax6 regulation of glutamatergic lineages in cerebellar development

EF 2021-22

Résumé
Pax6 is a key gene in the development of many regions of the brain. When it is mutated it causes a diverse set of abnormalities that include the absence of an iris and autism. To understand how Pax6 regulates brain development we have focused on the cerebellum for multiple reasons. First, it is composed of a limited number of cells that have a very well-detailed development. Second, only two classes of neurons are produced from the neuroepithelium of the cerebellum and one of these sets of cells, the cells that use glutamate as their neurotransmitter, are all affected by mutations of Pax6. Third, the recent ability to assess gene expression of single cells allows us to look at the genes of single cell types that are altered by the elimination of Pax6 and studies with identification of DNA that bind specifically to the Pax6 protein can identify target genes that are regulated by Pax6. Finally, the analysis of large data sets, termed bioinformatics, can permit us to put all these elements together to describe in impressive detail how a single gene can determine the final developmental state of multiple cell types. In this proposal, we do this with three sets of experiments: 1) State of the art single cell gene product analysis will be applied to normal and Pax6 mutant cerebellum to identify the genes that are significantly mis-expressed in the mutant cerebellum at critical points in development; 2) Chromatin immunoprecipitation with an antibody to Pax6 will be used to determine the elements of DNA that are regulated by Pax6; and 3) Focus will be on the validation of Pax6-driven pathways in the granule cells using cell culture and whole animal approaches. These studies will lead to an unprecedented view of how Pax6 orchestrates the development of such a complex organ as the brain and provide insights about how interventions may ameliorate disorders that come from mutations in the Pax 6 gene.
Programme
Project Grant
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
462507
Name
Goldowitz Daniel
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Developmental Biology
Projecttitle
Pax6 regulation of glutamatergic lineages in cerebellar development
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$841,500
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cell Specification; Cerebellar Development; Chromatin Accessibility; Developmental Genetics; Gene Action; Genetic Determinants Of Survival; Mouse; Pax6; Single Cell Rnaseq; Transcriptional Regulation
Abstract
Pax6 is a key gene in the development of many regions of the brain. When it is mutated it causes a diverse set of abnormalities that include the absence of an iris and autism. To understand how Pax6 regulates brain development we have focused on the cerebellum for multiple reasons. First, it is composed of a limited number of cells that have a very well-detailed development. Second, only two classes of neurons are produced from the neuroepithelium of the cerebellum and one of these sets of cells, the cells that use glutamate as their neurotransmitter, are all affected by mutations of Pax6. Third, the recent ability to assess gene expression of single cells allows us to look at the genes of single cell types that are altered by the elimination of Pax6 and studies with identification of DNA that bind specifically to the Pax6 protein can identify target genes that are regulated by Pax6. Finally, the analysis of large data sets, termed bioinformatics, can permit us to put all these elements together to describe in impressive detail how a single gene can determine the final developmental state of multiple cell types. In this proposal, we do this with three sets of experiments: 1) State of the art single cell gene product analysis will be applied to normal and Pax6 mutant cerebellum to identify the genes that are significantly mis-expressed in the mutant cerebellum at critical points in development; 2) Chromatin immunoprecipitation with an antibody to Pax6 will be used to determine the elements of DNA that are regulated by Pax6; and 3) Focus will be on the validation of Pax6-driven pathways in the granule cells using cell culture and whole animal approaches. These studies will lead to an unprecedented view of how Pax6 orchestrates the development of such a complex organ as the brain and provide insights about how interventions may ameliorate disorders that come from mutations in the Pax 6 gene.
Competitiondate
202203
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Goldowitz, Daniel; Pavlidis, Paul
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $841,500~ $0~